Skip to main content
IRWD $4.67 -2.41%
IRWD logo
IRWD · Ironwood Pharmaceuticals Inc
Track IRWD — free
$4.67 -0.12 (-2.41%) Play latest call Q3 2026 earnings call transcript
Market Cap
$767.33M
Shares
165.55M
Volume · Nov 19 948.72K Avg daily vol (3M) 2.1M
All webcasts

Earnings call · FY2026 Q2

Ironwood Pharmaceuticals Inc (IRWD) Q2 2026 Earnings Call

Concluded Aug 6, 2026
Aug 6, 2026
Period
FY2026 Q2
Runtime
—
Sources
2 artifacts
Revenue $113.04M +32.6% YoY
Diluted EPS $0.31 +121.4% YoY
Net income $51.29M +117.3% YoY
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

3 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 6, 2026.

Metric Guided
U.S. LINZESS Net Sales table Raised
2026
$1.15B – $1.2B
Total Revenue table Raised
2026
$460M – $485M
Adjusted EBITDA table
2026
at least $310M
Full-screen source Call document